Navigation Links
Toray to establish water treatment R&D center at NTU in Singapore
Date:6/24/2009

Today, Toray Industries, Inc., a multinational corporation headquartered in Japan and the world's largest producer of carbon fiber, announced the establishment of Toray Water Technology Laboratory (TWTL) in Singapore to conduct research and development of water treatment technologies. Nanyang Technological University (NTU)'s Nanyang Environment and Water Research Institute (NEWRI) is chosen as the choice partner for its research activities in Singapore.

"NTU welcomes TWTL as a partner for research activities. Such collaborative research is very much aligned with our efforts to promote and develop a strong research environment through interaction with industry partners. Collaboration with world-leading companies such as Toray also helps to enhance Singapore's position as a global water hub. Launched in 2008, NEWRI is the progression of NTU's efforts in environmental and water technologies (EWT) wherein these efforts are closely coordinated to provide a clearly defined window through which industry and research partners can access NTU's comprehensive EWT capabilities," says Professor Ng Wun Jern, Executive Director, NEWRI.

TWTL is part of Toray's vision to be a leading membrane manufacturer by 2010, particularly in the reverse osmosis membrane market for seawater desalination and reclamation of wastewater. TWTL, which will be housed in NTU's NEWRI, is supported by PUB Singapore's national water agency, the Economic Development Board (EDB), and NEWRI's R&D centres Singapore Membrane Technology Centre (SMTC) and Institute of Environmental Science and Engineering (iESE).

"Toray's corporate philosophy is to contribute to society through the creation of new value by innovative ideas, technologies and products. Toray began the R&D on reverse osmosis (RO) membrane in 1968, and as a result of the continuous R&D effort, its product line has been expanded to a full line up of water treatment membranes from RO to NF, UF, MF and MBR. This means Toray is a typical organic growth company based on its own technologies. We would like to refine our technologies and product quality by collaborating with NTU's leading edge technologies of water treatment, membrane and membrane processes," says Dr. Tadahiro Uemura, Director, Toray Industries, Inc.

The focus of TWTL's research and development activities are on membrane-based water treatment technologies. For its inaugural project, Toray is collaborating with NEWRI to develop innovative water treatment technologies in the area of membrane fouling mechanism. The joint research will be led by Professor Ng who is also an international authority in water and wastewater treatment technology.

Professor Ng adds, "Partnership with industry partners is a good reflection of NEWRI's emphasis on excellent science, and our interest to translate cutting-edge environmental and water technologies research results into innovative business solutions that will benefit the industry and society. We look forward to working with Toray and to the anticipated breakthroughs arising from our joint efforts."

Mr Manohar Khiatani, Deputy Managing Director of the Singapore Economic Development Board (EDB) said, "We are delighted that Toray, a global leader in membrane technology, has decided to collaborate with our NEWRI. This underscores our position as a leading hydrohub and also reflects the strong ties between Japan and Singapore, which are both strongly committed to water-related R&D. We are confident that Singapore's advantages as an innovation hub will allow Toray to use our city-state as a test-bedding platform to develop new-generation water technologies."

To seal the research partnership, Professor Ng and Dr Uemura signed a Memorandum of Understanding (MOU) on 24 June 2009, at the Singapore International Water Week venue. Mr Khoo Teng Chye of PUB, Mr Manohar Khiatani of EDB and Dr Masaru Kurihara of International Desalination Association (IDA), witnessed the signing ceremony.

The centre will start research activities from September 2009 with a staff of five people including engineers and researchers dispatched from Japan in addition to local employees. Toray plans to expand the size of the laboratory's staff to 30 or more people over five years.

In December 2007, Toray signed an MOU regarding water treatment-related joint development with PUB. Under the agreement, PUB and Toray aim to train and nurture young engineers at universities in Singapore. The joint research with NTU announced this time is expected to also serve this purpose.

NEWRI is conceived as a centre of excellence in EWT research, education and technology development. It coordinates NTU's EWT "ecosystem" and brings about enhanced opportunities for Singapore-based researchers to work with leading international experts. While NTU's School of Civil and Environmental Engineering provides an academic foundation in EWT, NEWRI sets to nurture students further through postgraduate EWT programmes, such as the NEWRI Environmental Master of Science (NEMS) programme, offered in collaboration with Stanford University.


'/>"/>

Contact: Esther Ang
estherang@ntu.edu.sg
656-790-6804
Nanyang Technological University
Source:Eurekalert

Related medicine news :

1. ChromaDex Establishes a Blanket Purchase Agreement With the National Institutes of Health
2. Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
3. Major New Report Establishes Effective Methods of Enhancing and Preserving Brain Power as We Age
4. Cooperatives Can Address Health Care Needs if Properly Defined and Adequate Consumer Protections are Established
5. Childrens Hospital Boston, CompuCyte Corporation Establish International Quantitative Imaging Cytometry Center
6. DFG establishes nine new collaborative research centers
7. Restaurants and Foodservice Establishments Can Now Earn Green Seal Certification
8. IBM Establishes Global Healthcare Centre of Excellence in La Gaude, France
9. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
10. Study in Nature Medicine establishes major new treatment target in diseased arteries
11. New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... CA (PRWEB) , ... February 11, 2016 , ... ... was held in San Diego, CA, on February 6th & 7th, 2016 according to ... for those who were not invited to the NFL’s combine in Indianapolis,” says Husted. ...
(Date:2/11/2016)... Ore. (PRWEB) , ... February 11, 2016 , ... ... Medicaid coverage results in significantly higher rates of several common cancer screenings, especially ... resulting in better outcomes and survival rates. , The study,“What Does Medicaid ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... (WMIS), known as the World Molecular Imaging Congress (WMIC), will be held in ... the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize ...
(Date:2/10/2016)... ... 10, 2016 , ... LaserShip, a regional parcel carrier that services the eastern ... Michigan last Friday in order to aid in the Flint water crisis. In 2014, ... facility located in Clio, only 15 miles away from Flint. , “We have deep ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... its revolutionary new 2.0 version at the International Roofing Expo in Orlando, Florida ... of the world's most advanced weather technology in the hands of consumers, roofing ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... OR AKIVA, Israel , February 10, ... Ltd., a leader in the field of cartilage repair, ... on February 5, 2016. The $15 million investment was ... leading Chinese pharmaceutical manufacturer, and was joined by existing ... Financial Holdings and both the Technion Research & Development ...
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
(Date:2/10/2016)... 2016  Silicon Biosystems Menarini Inc., a developer ... uncover the biological complexities of disease at the ... of innovative technologies for genomics research, today announced ... enabling translational researchers to obtain high-quality sequencing results ... and normal cells in an optimized and seamless ...
Breaking Medicine Technology: